
CVS Health Corp
NYSE:CVS

Intrinsic Value
The intrinsic value of one
CVS
stock under the Base Case scenario is
145.44
USD.
Compared to the current market price of 63.68 USD,
CVS Health Corp
is
Undervalued by 56%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
CVS Health Corp
Fundamental Analysis


Revenue & Expenses Breakdown
CVS Health Corp
Balance Sheet Decomposition
CVS Health Corp
Current Assets | 73.2B |
Cash & Short-Term Investments | 12.7B |
Receivables | 39.6B |
Other Current Assets | 20.9B |
Non-Current Assets | 182.4B |
Long-Term Investments | 28.9B |
PP&E | 28.6B |
Intangibles | 117.8B |
Other Non-Current Assets | 7.2B |
Free Cash Flow Analysis
CVS Health Corp
USD | |
Free Cash Flow | USD |
Earnings Waterfall
CVS Health Corp
Revenue
|
379B
USD
|
Cost of Revenue
|
-325.7B
USD
|
Gross Profit
|
53.2B
USD
|
Operating Expenses
|
-43.1B
USD
|
Operating Income
|
10.1B
USD
|
Other Expenses
|
-4.8B
USD
|
Net Income
|
5.3B
USD
|
CVS Profitability Score
Profitability Due Diligence
CVS Health Corp's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Score
CVS Health Corp's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
CVS Solvency Score
Solvency Due Diligence
CVS Health Corp's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Score
CVS Health Corp's solvency score is 34/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CVS Price Targets Summary
CVS Health Corp
According to Wall Street analysts, the average 1-year price target for
CVS
is 79.23 USD
with a low forecast of 70.7 USD and a high forecast of 99.75 USD.
Dividends
Current shareholder yield for CVS is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CVS
stock under the Base Case scenario is
145.44
USD.
Compared to the current market price of 63.68 USD,
CVS Health Corp
is
Undervalued by 56%.